hasRouteOfAdministration
P23149
predicate
Indicates that one entity specifies the method or pathway by which another entity (typically a substance or medication) is administered.
All labels observed (5)
| Label | Occurrences |
|---|---|
| routeOfAdministration | 216 |
| hasRouteOfAdministration canonical | 183 |
| isParenteralDrug | 1 |
| isRouteOfAdministration | 1 |
| usesRouteOfAdministration | 1 |
Sample triples (402)
| Subject | Object |
|---|---|
| Tecfidera | oral ⓘ |
| Leqembi | intravenous infusion ⓘ |
| Plegridy | subcutaneous injection ⓘ |
| Plegridy | subcutaneous ⓘ |
| Spinraza | intrathecal via predicate surface "routeOfAdministration" ⓘ |
| Spinraza | lumbar puncture via predicate surface "routeOfAdministration" ⓘ |
| Tysabri | intravenous infusion via predicate surface "routeOfAdministration" ⓘ |
| Vumerity | oral ⓘ |
| Aduhelm | intravenous infusion via predicate surface "routeOfAdministration" ⓘ |
| Fampyra | oral ⓘ |
| Lucentis | intravitreal injection ⓘ |
| Xolair | subcutaneous injection ⓘ |
| Xolair | subcutaneous ⓘ |
| Tecentriq | intravenous infusion via predicate surface "routeOfAdministration" ⓘ |
| Tylenol | oral via predicate surface "routeOfAdministration" ⓘ |
| Tylenol | rectal via predicate surface "routeOfAdministration" ⓘ |
| Listerine | topical oral use via predicate surface "routeOfAdministration" ⓘ |
| Remicade | intravenous infusion ⓘ |
| Xarelto | oral via predicate surface "isRouteOfAdministration" ⓘ |
| Darzalex | intravenous infusion ⓘ |
| Darzalex | subcutaneous injection ⓘ |
| Janssen COVID-19 Vaccine | intramuscular injection via predicate surface "routeOfAdministration" ⓘ |
| Imbruvica | oral ⓘ |
| Avastin | intravenous infusion via predicate surface "routeOfAdministration" ⓘ |
| Herceptin | intravenous infusion via predicate surface "routeOfAdministration" ⓘ |
| Rituxan | intravenous infusion via predicate surface "routeOfAdministration" ⓘ |
| Activase | intravenous via predicate surface "routeOfAdministration" ⓘ |
| Perjeta | intravenous infusion via predicate surface "routeOfAdministration" ⓘ |
| Stelara | subcutaneous injection ⓘ |
| Stelara | intravenous infusion ⓘ |
| oseltamivir | oral ⓘ |
| oseltamivir | oral capsule ⓘ |
| oseltamivir | oral suspension ⓘ |
| rVSV-ZEBOV | intramuscular injection via predicate surface "routeOfAdministration" ⓘ |
| zanamivir | inhalation ⓘ |
| zanamivir | intravenous ⓘ |
| zanamivir | intranasal ⓘ |
| zanamivir | oral (investigational, low bioavailability) ⓘ |
| BCG vaccine | intradermal injection via predicate surface "routeOfAdministration" ⓘ |
| REGN-EB3 | intravenous infusion via predicate surface "routeOfAdministration" ⓘ |
| mAb114 | intravenous infusion via predicate surface "routeOfAdministration" ⓘ |
| rivastigmine | oral ⓘ |
| rivastigmine | transdermal ⓘ |
|
memantine
surface form:
Memantine
|
oral via predicate surface "routeOfAdministration" ⓘ |
| ENGAGE (Study 301) | intravenous via predicate surface "routeOfAdministration" ⓘ |
| Donepezil | oral via predicate surface "routeOfAdministration" ⓘ |
| Trulicity | subcutaneous injection via predicate surface "routeOfAdministration" ⓘ |
| Zepbound | subcutaneous injection via predicate surface "routeOfAdministration" ⓘ |
| Cymbalta | oral ⓘ |
| Alimta | intravenous ⓘ |